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A new histological classification of neuroendocrine tumors (NETs) was established in 
WHO 2010. ENET and NCCN proposed treatment algorithms for colorectal NET. 
Retrospective study of NET of the large intestine (colorectal and appendiceal NET) was 
performed among institutions allied with the Japanese Society for Cancer of the Colon 
and Rectum, and 760 neuroendocrine tumors from 2001 to 2011 were re-assessed 
using WHO 2010 criteria to elucidate the clinicopathological features of NET in the large 
intestine. Next, the clinicopathological relationship with lymph node metastasis was 
analyzed to predict lymph node metastasis in locally resected rectal NET. The primary 
site was rectum in 718/760 cases (94.5%), colon in 30/760 cases (3.9%), and appendix 
in 12/760 cases (1.6%). Patients were predominantly men (61.6%) with a mean age 
of 58.7  years. Tumor size was <10 mm in 65.4% of cases. Proportions of NET G1, 
G2, G3, and mixed adeno-neuroendocrine carcinoma (MANEC) were 88.4, 6.3, 3.9, 
and 1.3%, respectively. Of the 760 tumors, 468 were locally resected, and 292 were 
surgically resected with lymph node dissection. Rectal NET showed a higher proportion 
of NET G1, and colonic and appendiceal NET was more commonly G3 and MANEC. 
Of the 292 surgically resected cases, 233 NET G1 and G2 located in the rectum were 
used for the prediction of lymph node metastasis. Lymphatic and blood vessel invasion 
were independent predictive factors of lymph node metastasis. NET G2 cases showed 
more frequent lymph node metastasis than that seen in NET G1 cases, but this was 
not an independent predictor of lymph node metastasis. Of the 98 surgically resected 
cases <10 mm in size, we found 9 cases with lymph node metastasis (9.2%). All cases 
were NET G1, and eight of the nine cases were positive either for lymphatic invasion or 
blood vessel invasion. Using the WHO classification, we found NET in the large intestine 
showed a tumor-site-dependent variety of histological and clinicopathological features. 
Risk of lymph node metastasis in rectal NET was confirmed even in lesions smaller than 
10 mm. Concordant assessment of vascular invasion will be required to estimate lymph 
node metastasis in small lesions.
Keywords: neuroendocrine tumor, carcinoid tumor, WhO classification 2010, lymph node metastasis, rectum, 
colon
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inTrODUcTiOn
A new histological classification of neuroendocrine tumors 
(NETs) was determined in the WHO 2010 classification, and the 
UICC TNM classification seventh edition or ENET classification 
proposed the staging of gastrointestinal NET (1–3). NETs arise 
from the whole organ, and gastrointestinal NET was traditionally 
divided by the embryological origin of the foregut, midgut, and 
hindgut. Midgut and hindgut NET arise in the large intestine 
and the variable histologic features of NET in this organ could 
complicate identification even when using identical WHO 2010 
classifications. Furthermore, large clinicopathological data sets 
of NET based on the WHO 2010 classification are not available, 
and the utility of the WHO 2010 classification as a prognostic 
factor is not well established in NET of the large intestine. 
Recently, clinical guidelines for gastrointestinal NET were also 
proposed by NCCN and ENET (4, 5). However, the indication 
for local excision or endoscopic resection in small lesions is not 
fully determined (6). Similar to early colorectal adenocarcinoma, 
the clinicopathological association between colorectal NET and 
lymph node status in surgically resected cases has been studied to 
predict lymph node metastasis (7, 8). In this study, retrospective 
assessment of NET of the large intestine (colorectal and appen-
diceal NET) was performed among the 68 Japanese institutions 
allied with the Japanese Society for Cancer of the Colon and 
Rectum (JSCCR) to clarify the clinicopathological features of 
NET in the large intestine using WHO 2010 criteria. Next, using 
surgically resected rectal NET G1 and G2, the clinicopathological 
relationship with lymph node metastasis was analyzed to assess 
the current therapeutic algorithm.
MaTerials anD MeThODs
Pathological re-evaluations of NET according to the WHO 2010 
criteria were performed in cases with NET of the large intestine 
removed from 2001 to 2011 in the 68 institutions of the JSCCR. 
The collected clinicopathological information was patient age, 
sex, tumor size, tumor location, pathological diagnosis based on 
WHO 2010 criteria, depth of tumor invasion, mitotic index [<2/10 
high power fields (HPF), 2–20/10 HPF, or >20/10 HPF], Ki-67 
labeling index (≤2, 3–20, or >20%), and resection method (surgi-
cal, endoscopic, or other). Information of lymph node metastasis 
(present or absent) was collected in all surgically resected cases, 
and cases underwent radical surgery after the local resection were 
included in resected cases. These data were registered into a Web 
system developed by the JSCCR. Clinical outcome or prognosis 
was not investigated in this study. Clinicopathological features 
of NET in the large intestine were evaluated, and compared 
among rectal, colonic, and appendiceal NET, and the association 
between clinicopathological features and lymph node metastasis 
was assessed using surgically resected rectal NET G1 and G2 to 
estimate risk factors of lymph node metastasis in locally resected 
tumors. This study was approved by the review board in the 
JSCCR and National Cancer Center (2014-332).
statistical analysis
All continuous data were described as mean and SD in this study. 
As therapeutic strategy of NET in large intestine is divided by 
tumor size of 10 and 20  mm, case number and frequency of 
the tumors <10, ≥10 and <20, and ≥20  mm were calculated. 
Comparison of clinicopathological features among rectal, 
colonic, and appendiceal NET was performed using the χ2-test 
and Student’s t-test.
Clinicopathological factors associated with lymph node 
metastasis in rectal NET G1 and G2 were assessed using χ2-test 
and Student’s t-test, and multiple logistic regression analyses were 
performed to identify independent predictive factors of synchro-
nous lymph node metastasis. A probability value of <0.01 was 
regarded as statistically significant in this study.
resUlTs
In this study, 760 cases from 68 institutions were entered and 
clinicopathological features were evaluated (Table 1). Of the 760 
tumors, 718 (94.5%) were located in the rectum, 30 (3.9%) were 
in the colon, and 12 (1.6%) were in the appendix. In total, 461 
(60.7%) patients were men and 299 (39.3%) were women, with 
a mean age of 58.7 years. The frequencies of NET G1, G2, NEC 
(G3), and mixed adeno-neuroendocrine carcinoma (MANEC) 
were 672 (88.4%), 48 (6.3%), 30 (3.9%), and 10 (1.3%), respec-
tively. Of the 760 NET, 468 were locally resected, and 292 were 
surgically resected with lymph node dissection, which included 
cases who underwent radial surgery after the local resection. 
As for tumor size, the mean size was 11.7 mm, and 497 tumors 
(65.4%) were smaller than 10 mm. Most tumors were limited to 
the mucosa or submucosa (657 cases, 86.4%), showed mitosis in 
<2/10 HPF (694 cases, 91.3%), and had a Ki-67 index of ≤2% 
(675 cases, 88.8%). Lymphatic vessel invasion and blood ves-
sel invasion were found in 136 (17.9%) and 173 (22.8%) cases, 
respectively. Lymph node metastasis was found in 108 cases of 
292 surgically resected cases (37.0%). As for clinicopathologic 
differences among colonic, rectal, and appendiceal NETs, 
patient ages were different among them, significantly (P < 0.01), 
and were in the order of colonic (68.6  ±  11.9  years), rectal 
(58.6 ±  12.4  years), and appendiceal NET (44.7 ±  22.6  years). 
Distribution of histological grade was also different between 
rectal NET and others. Compared with colonic and appendiceal 
NET, rectal NET was predominantly NET G1 (656 cases, 91.4%). 
However, colonic NET included more NET G3/NEC (14 cases, 
46.7%) and MANEC (6 cases, 20.0%), and appendiceal NET 
included more NET G3/NEC (7 cases, 58.3%). Most of the local 
resections were performed in rectal NET (467/468 cases, 99.8%). 
Tumor sizes were 9.7 ± 12.3 mm for rectal NET, 51.3 ± 37.8 mm 
for colonic NET, and 28.8 ± 36.2 mm for appendiceal NET; rectal 
NETs were significantly smaller than colonic and appendiceal 
NET (P < 0.01). The distribution of tumor depth is also different 
between rectal NET and others, and tumor depth in rectal NET 
was limited to the mucosa or submucosa in 684 cases (95.3%), 
while over half of colonic and appendiceal NET invaded the 
muscular layer or deeper (P < 0.01). Concordant with WHO 2010 
criteria, cases with low mitotic and Ki-67 indices were seen more 
often in rectal NET than in others. Lymphatic vessel and blood 
vessel invasions were more frequently seen in colonic NET than 
in rectal NET. Also, lymph node metastasis in surgically resected 
cases was seen more frequently in colonic NET than in others, 
significantly (P < 0.01).
TaBle 1 | clinicopathological features of colorectal neuroendocrine tumor based on WhO 2010 criteria.















No. of cases 760 718 (94.5%) 30 (3.9%) 12 (1.6%)
Age (years) Mean ± SD 58.7 ± 12.8 58.6 ± 12.4 68.6 ± 11.7 44.7 ± 22.6 >0.01 >0.01 >0.01
Sex Men 461 (60.7%) 435 (60.4%) 20 (66.6%) 6 (50.0%) 0.50 0.46 0.31
Women 299 (39.3%) 283 (39.4%) 10 (33.3%) 6 (50.0%)
WHO 2010 criteria NET G1 672 (88.4%) 656 (91.4%) 9 (30.0%) 3 (25.0%) >0.01 >0.01 0.18
NET G2 48 (6.3%) 44 (6.1%) 1 (3.3%) 2 (16.7%)
NET G3/NEC 30 (3.9%) 14 (2.0%) 14 (46.7%) 7 (58.3%)
MANEC 10 (1.3%) 4 (0.6%) 6 (20.0%) 0 (0%)
Resection Surgically 292 (38.4%) 251 (35.0%) 29 (96.7%) 12 (100%) >0.01 >0.01 0.52
Locally 468 (61.6%) 467 (65.0%) 1 (3.3%) 0 (0%)
Tumor size Mean ± SD 11.7 ± 16.9 9.7 ± 12.3 51.3 ± 37.8 28.8 ± 36.2 >0.01 >0.01 0.09
<10 mm 497 (65.4%) 490 (68.2%) 4 (13.3%) 3 (25.0%) >0.01 >0.01 0.66
≥10 mm, <20 mm 180 (23.7%) 176 (24.5%) 3 (10.0%) 1 (8.3%)
≥20 mm 83 (10.9%) 52 (7.2%) 23 (76.7%) 8 (66.7%)
Tumor depth Limited to mucosa (%) 32 (4.2%) 32 (4.5%) 0 (0%) 0 (0%) >0.01 >0.01 0.25
Invades submucosa (%) 625 (82.2%) 652 (90.8%) 4 (13.3%) 1 (8.3%)
Invades muscularis propria (%) 42 (5.5%) 39 (5.4%) 2 (6.7%) 1 (8.3%)
Invades into subserosa or 
non-peritonealized pericolonic 
or perirectal tissue (%)
38 (5.0%) 21 (2.9%) 9 (30.0%) 8 (66.7%)
Invades peritoneum or other 
organs (%)






694 (91.3%) 676 (94.2%) 9 (30.0%) 9 (75.0%) >0.01 0.02 0.012
31 (4.1%) 25 (3.5%) 4 (13.3%) 2 (16.7%)
35 (4.6%) 17 (2.4%) 17 (56.7%) 1 (8.3%)
Ki-67 index (%) ≤2 (%) 675 (88.8%) 659 (91.8%) 9 (30.0%) 7 (58.3%) >0.01 >0.01 0.03
<2, ≤20 (%) 48 (6.3%) 42 (5.8%) 3 (10.0%) 3 (25.0%)
>20 (%) 37 (4.9%) 17 (2.4%) 18 (60.0%) 2 (16.7%)
Lymphatic vessel 
invasion
Absent (%) 624 (82.1%) 607 (84.5%) 9 (30.0%) 8 (66.7%) >0.01 >0.01 0.18
Present (%) 136 (17.9%) 111 (15.5%) 21 (70.0%) 8 (66.7%)
Blood vessel invasion Absent (%) 587 (77.2%) 572 (79.7%) 7 (23.3%) 8 (66.7%) >0.01 0.27 >0.01
Present (%) 173 (22.8%) 146 (20.3%) 23 (76.7%) 4 (33.3%)
Lymph node 
metastasis
Absent (% in surgical cases) 184 (63.0%) 166 (66.1%) 8 (27.6%) 10 (83.3%) >0.01 0.22 >0.01
Present (% in surgical cases) 108 (37.0%) 85 (33.9%) 21 (72.4%) 2 (16.7%)
Clinicopathologic features of colorectal neuroendocrine tumors removed from a Japanese cohort from 2001 to 2011 and retrospectively classified using the WHO 2010 criteria.
NEC, neuroendocrine carcinoma; NETs, neuroendocrine tumors; MANEC, mixed adeno-neuroendocrine carcinoma.
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Next, we investigated the risk factor of synchronous lymph 
node metastasis, especially in small rectal NET G1 and G2. At 
first, we evaluated the association between clinicopathological 
features and lymph node metastasis using all 233 surgically 
resected rectal NET G1 and G2. Clinicopatholgoical features 
are shown in Table 2, and lymph node metastasis was found in 
70 cases (30.0%) in these cases. Table  3 shows the association 
between clinicopathological features and lymph node metastasis. 
NET G2, large tumor size, tumor invasion into the muscularis 
propria or deeper, high mitotic index, high Ki-67 index, lym-
phatic vessel invasion, and blood vessel invasion were associated 
with lymph node metastasis in univariate analysis. Furthermore, 
lymphatic and blood vessel invasion were independent predictors 
of lymph node metastasis in multivariate analysis. Although NET 
G2 cases showed more lymph node metastasis than that seen in 
NET G1 cases, that was not an independent predictor of lymph 
node metastasis in rectal NET. Table 4 (A) shows the association 
between clinicopathological features and lymph node metastasis 
in surgically resected rectal NET G1 and G2 <20 mm. Tumor size, 
lymphatic invasion, and blood vessel invasion were independent 
predictors of lymph node metastasis. NET G2 cases tended to show 
more frequent lymph node metastasis, but this difference was not 
statistically significant. Of 489 rectal NET G1 and G2 <10 mm, 98 
were surgically resected, and 391 were locally resected. The dif-
ferences between them are shown in Table 5. Surgically resected 
cases were larger and showed more frequent lymphatic vessel 
and blood vessel invasion than that seen with locally resected 
cases, and lymph node metastasis was seen in 9 cases (9.2%) of 
98 surgically resected cases. A clinicopathological comparison 
between cases with and without lymph node metastasis is shown 
in Table 4 (B). Of the clinicopathological features, although not 
an independent risk factor in multivariate analysis, blood vessel 





P value (univariate  
analysis)
P value (multivariate  
analysis)
Age (years) Range (mean ± SD) 56.3 ± 11.3 58.3 ± 12.2 0.24
Sex Men 39 94 0.78
Women 31 69
Location Upper rectum 7 30 0.11
Lower rectum 63 133
WHO 2010 criteria NET G1 54 147 P < 0.01 0.89
NET G2 16 16
Tumor size (mm) Range (mean ± SD) 16.6 ± 9.9 11.3 ± 13.3 P < 0.01 0.08
Tumor depth Limited to mucosa or submucosa 45 144 P < 0.01 0.05
Invades muscularis propria or deeper 25 19
Mitotic index (/10HPF) <2 58 154 P < 0.01
≤2, ≤20 12 9
Ki-67 index (%) ≤2 16 15 P < 0.01
<2, ≤20 54 148
Lymphatic vessel invasion Absent 32 133 P < 0.01 P < 0.01
Present 38 30
Blood vessel invasion Absent 28 121 P < 0.01 P < 0.01
Present 42 42
Study population described in Table 1.
NETs, neuroendocrine tumors.
TaBle 2 | clinicopathological features of surgically resected rectal neT 
g1 and g2 based on WhO 2010 criteria.
Total cases 233
Age (years) Mean ± SD 57.7 ± 12.0




NET G1 201 (86.3%)
NET G2 32 (13.7%)
Tumor size (mm) Mean ± SD 12.9 ± 12.6
Location Upper rectum 37 (15.9%)
Lower rectum 196 (84.1%)
Tumor depth Limited to mucosa 6 (2.6%)
Invades submucosa 183 (78.5%)
Invades muscularis propria 34 (14.6%)
Invades into subserosa or non-peritonealized 
pericolonic or perirectal tissue
10 (4.3%)




≤2, ≤20 21 (9.0%)
Ki-67 index (%) ≤2 202 (86.7%)













Study population described in Table 1.
NETs, neuroendocrine tumors.
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Table 6. All nine cases were NET G1, and the tumor depth was 
limited to the mucosa or submucosa. Importantly, eight of the 
nine cases showed either lymphatic or blood vessel invasion.
DiscUssiOn
In this study, we examined the clinicopathological association 
with synchronous lymph node metastasis in surgically resected 
rectal NET G1 and G2. Gastrointestinal NET without lymph 
node metastasis can be cured by local resection. Although many 
primary NETs themselves can be removed endoscopically, lymph 
node metastases can remain. Therefore, prediction of lymph node 
metastasis using the primary tumor is important to determine a 
patient’s need for surgical resection with lymph node dissection. 
Tumor size and tumor depth have been reported to be important 
for the prediction of lymph node metastasis in rectal NET (9, 
10). T stage in current ENET TNM and AJCC/UICC TNM 
classification was determined by tumor size and depth. ENET 
and NCCN guidelines recommended local resection in tumors 
<20 mm and without muscular invasion which corresponding 
to pT1a and 1b (4, 5). However, our results from surgical speci-
mens of rectal NET G1 and G2 revealed that lymphatic vessel 
and blood vessel invasion was the independent risk factors of 
lymph node metastasis. Then, 26.5% of lymph node metastasis 
was found in tumors smaller than 20 mm. Furthermore, 9.2% 
of lymph node metastases were found in tumors smaller than 
10  mm, and most of these cases were positive for vascular 
invasion. Similar results were reported previously by Konishi 
et al. (11). They reported a 7% rate of lymph node metastasis in 
tumors smaller than 10 mm, and all cases had lymphatic vessel 
invasion. The JSCCR and Japan Neuroendocrine Tumor Society 
recommend, based on this result, local resection only for tumors 
smaller than 10 mm, and without muscular invasion or vascular 
invasion was found more frequently in cases with lymph node 
metastasis in the univariate analysis. The clinicopathological 
features of nine cases with lymph node metastasis are shown in 
TaBle 4 | association between clinicopathological features and lymph node metastasis in surgically resected rectal neT g1 and g2 <20 and <10 mm.
(a) association between clinicopathological features and lymph node 
metastasis in surgically resected rectal neT g1 and g2 <20 mm
(B) association between clinicopathological features and lymph node 
metastasis in surgically resected rectal neT g1 and g2 <10 mm
























Age (years; mean ± SD) 55.5 ± 11.6 58.2 ± 12.3 N.S Age (years; mean ± SD) 57.1 ± 8.8 57.7 ± 12.3 N.S
Sex Sex
Men 30 85 N.S Men 5 51 N.S
Women 23 62 Women 4 38
Location Location
Upper rectum 7 27 N.S Upper rectum 0 21 N.S
Lower rectum 46 120 Lower rectum 9 68
WHO 2010 criteria WHO 2010 criteria
NET G1 43 133 0.07 NET G1 9 85 N.S
NET G2 10 14 NET G2 0 4
Tumor size (mm; 
mean ± SD)
12.5 ± 3.5 8.5 ± 3.8 P < 0.01 P < 0.01 Tumor size (mm; 
mean ± SD)
7.2 ± 1.6 6.1 ± 2.0 N.S
Tumor depth Tumor depth N.S
Limited to mucosa or 
submucosa





13 16 Invades muscularis 
propria or deeper
0 3
Mitotic index (/10HPF) Mitotic index (/10HPF)
<2 45 139 0.03 <2 9 86 N.S
≤2, ≤20 8 8 ≤2, ≤20 0 3
Ki-67 index (%) Ki-67 index (%) N.S
≤2 42 134 0.02 ≤2 9 87
<2, ≤20 11 13 <2, ≤20 0 2
Lymphatic vessel invasion Lymphatic vessel 
invasion
0.02
Absent 26 121 P < 0.01 P < 0.01 Absent 5 76
Present 27 26 Present 4 13
Blood vessel invasion P < 0.01 P < 0.01 Blood vessel invasion <0.01 =0.01
Absent 22 109 Absent 3 68
Present 31 38 Present 6 21
Study population described in Table 1.
NETs, neuroendocrine tumors.
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invasion (12). There were no distinct guidelines about the indica-
tion of local resection during this study period of 2001 and 2011. 
Despite this, many clinicians in local institutions recommended 
surgical resection in tumors near 10 mm in size or cases with 
vascular invasion. Such a decision by local clinicians is thought 
to be reflected in the difference between surgically resected and 
locally resected cases in rectal NET <10 mm, where 9.2% of cases 
were positive for lymph node metastasis. Therefore, clinicians 
should remember that some cases <20 mm or even <10 mm in 
size may show lymph node metastasis in rectal NET. However, 
good clinical results after endoscopic resection of NET have 
also been reported (13). Therefore, further study with follow-up 
data is required to determine the optimal treatment algorithm 
in small rectal NET. All institutions in this study have also 
entered into a pathology survey, and their assessment statuses 
were investigated (14). In this survey, 88.6% of these institutions 
routinely performed immunohistochemical and histochemical 
staining in the diagnosis of NET, and 90.3% of these institutions 
routinely performed immunohistochemical and histochemi-
cal staining to assess vascular invasion. Detailed pathology 
evaluations were also performed by institutions entered in this 
study. Inter-observer differences in the assessment of vascular 
invasion have been reported. However, this difference seemed 
to be affected by the tumor size. Many NETs were found to be 
smaller than 10 mm in this study. Therefore, vascular invasion 
in rectal NET with a small size can be concordantly assessed 
(15, 16). Pathological analyses used in treatment algorithms 
should be designed to ensure objectivity in the assessment of 
vascular invasion in NET. In addition to the utility of describing 
histological features of NET from different organs, NET clas-
sification can be a predictive or prognostic factor. Our result 
revealed that G2 classified tumors in the WHO 2010, although 
not an independent risk factor did show more frequent lymph 
node metastasis. However, this study did not investigate clini-
cal outcomes and recurrence, and these associations with NET 
classification should be investigated in the future. Similarly, this 
TaBle 6 | lymph node metastasis in neT g1and g2 <10 mm.
no age  
(years)
sex Tumor  
size  
(mm)





WhO 2010  
classification
1 71 M 8 SM + + G1
2 49 F 6 SM − + G1
3 50 M 6 SM − + G1
4 61 M 8 SM + + G1
5 62 F 8 SM − + G1
6 42 F 8 SM + – G1
7 63 M 4 SM − + G1
8 60 M 8 SM − − G1
9 56 F 9 SM + − G1
Study population described in Table 1.
NETs, neuroendocrine tumors.
TaBle 5 | clinicopathological difference between locally resected and surgically resected rectal neT g1 and g2 <10 mm.
Treatment
n = 489 local resection surgical resection P value (univariate analysis)
391 98
Age (years) Range (mean ± SD) 58.3 ± 12.7 57.6 ± 12.0 0.62
Sex Men 238 56 0.50
Women 153 42
Location Upper rectum 73 21 0.54
Lower rectum 318 77
WHO 2010 criteria NET G1 382 94 0.07
NET G2 9 4
Tumor size (mm) Range (mean ± SD) 6.2 ± 2.0 5.2 ± 2.0 P < 0.01
Tumor depth Limited to mucosa or submucosa 368 95 0.03
Invades muscularis propria or deeper 2 3
Mitotic index (/10HPF) <2 388 96 0.26
≤2, ≤20 3 2
Ki-67 index (%) ≤2 383 95 0.54
<2, ≤20 8 3
Lymphatic vessel invasion Absent 372 81 P < 0.01
Present 19 17
Blood vessel invasion Absent 357 71 P < 0.01
Present 34 27
Study population described in Table 1.
NETs, neuroendocrine tumors.
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study investigated only resectable tumors and distant metastasis 
was not investigated. Further clinicopathological analysis will 
be required to investigate risk factor of metachronal distant 
metastasis.
This multi-institutional study also provided extensive clinico-
pathological information about NET of the large intestine in Japan 
according to NET classifications. Rectal NET has been reported 
to occur with higher frequency among Asian/Pacific islanders 
(16). In this study, we also found a very high frequency of rectal 
NET in the Japanese population, and tumor distributions in the 
large intestine are thought to be much different from that seen 
in Western countries (17). Next, we also found site-dependent 
histological variation within the large intestine in the Japanese 
cohort (18). Over 90% of rectal carcinoids were NET G1, and 
the ratio was higher than that found in the colon or appendix. 
This predominant incidence of G1 in rectal NET is also higher 
than the 40–70% range of NET in other gastrointestinal organs 
reported previously (19–23). Therefore, this report revealed that 
in addition to the tumor size or invasion, the distribution of 
histological grade and type is also variable among rectal, colonic, 
and appendiceal NET in Asian populations. Furthermore, we 
first reported the incidence of MANEC in the colon and rectum; 
MANEC were found in 1.3% of total cases, and were more 
frequently seen in colonic NET. Further study will be required 
to establish a therapeutic strategy for MANEC. We succeeded to 
elucidate anatomical site-dependent histological variety of NET 
in large intestine using uniform classification. WHO 2010 criteria 
can be used to understand the histological and biological variety 
of NET within whole body.
In conclusion, the clinicopathological features of NET were 
variable among the rectum, colon, and appendix, and histological 
variability among them clearly emerged using the NET classifica-
tion. In rectal NET, our study revealed lymph node metastases 
even in tumors smaller than 10 mm, demonstrating that indica-
tions for surgical resection should be re-examined, especially in 
small NET with vascular invasion.
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